Digitalization offers Medical Affairs teams the opportunity to rethink strategy and actions across the lifecycle of traditional and nontraditional products.
In this podcast, we speak with presenters of the MAPS 2022 Global Annual Meeting session, “Developing and Executing and Integrated Medical Communications Strategy and Plan.”
In this final article in the Leadership Perspectives series, John Pracyk interviews J&J leaders to explore a bold vision of career development that entails moving across sectors; namely, crossing over between Pharmaceuticals, Medical Devices, Vision, and Consumer Health.
In conversation with John Pracyk, MD, PhD, MBA, Medical Affairs leaders from Johnson & Johnson describe best practices to prepare our next generation of Chief Medical Officers.
This webinar addresses the importance of metrics and how Share of Scientific Voice provides measurement in one of MA’s most strategically important areas.
A guide for Medical Communications cross-functional collaboration to develop an Integrated Medical Communications Strategy and Plan (iMC S/P) which is the roadmap for how a Medical Affairs team communicates its product vision and value proposition to internal and external stakeholders.
In this webinar, our panelists share their experience, challenges, and practical solutions regarding driving insights into action.
In this installment of the Leadership Perspectives series, we speak with some of the top Medical Affairs leaders from Johnson & Johnson as they think about the rapid new ascension of Medical Affairs into a fully integrated strategic business partner.
This podcast focuses on the Medical Productivity Index (MPI), which seeks to quantify aspects of Medical Affairs including the MSL/HCP relationship and an individual’s impact on patient outcomes.
MAPS speaks with Ariel Katz, co-founder and CEO of H1, about the future of the Medical Affairs function and the factors driving the current pace of change.